Arrowhead CEO: We feel 'great' about the drug
0
Arrowhead Research Chief Executive Chris Anzalone contends the company's hepatitis B drug has potential.
Arrowhead Research Chief Executive Chris Anzalone contends the company's hepatitis B drug has potential.